“…In addition, the enriched KEGG pathways derived from resveratrol gene sets also discovered 10 genes, CREBBP, HSP90B1, CTNNB1, PTEN, NFKBIA, TP53, HSP90AA1, CDKN1A, RELA and TCF7L2 (EntrezGene ID: 1387, 7184, 1499, 5728, 4792, 7157, 3320, 1026, 5970 and 6934), all associated with prostate cancer (Table 3). It is noteworthy that anti-carcinogenic properties of resveratrol have been observed in other solid tumors including the highly fatal pancreatic cancer [18, 19]. Evidence has also been garnered recently that resveratrol demonstrates efficacy in the treatment of inflammation-induced pancreatitis [20, 21].…”